Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,155,408
-
Share change
-
-249,376
-
Total reported value
-
$509,245,856
-
Put/Call ratio
-
0%
-
Price per share
-
$161.33
-
Number of holders
-
247
-
Value change
-
-$41,077,760
-
Number of buys
-
70
-
Number of sells
-
131
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2025
As of 30 Jun 2025,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,155,408 shares.
The largest 10 holders included
MORGAN STANLEY, LPL Financial LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, UBS Group AG, Royal Bank of Canada, RAYMOND JAMES FINANCIAL INC, ENVESTNET ASSET MANAGEMENT INC, Berger Financial Group, Inc, and GOLDMAN SACHS GROUP INC.
This page lists
248
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.